Hybio Pharmaceutical Co., Ltd. Class A 300199
SZSE · China · Health Technology
CNY 23.92+1.13 (+4.96%)
Market closed· · CNY · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · CNY · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise |
|---|---|---|---|---|---|---|
| Q2 2026 | 2024-10-29 | — | — | — | CNY 120.00M | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.